Miramar Capital, LLC Abbott Laboratories Transaction History

Miramar Capital, LLC

$407 Million
Q1 2024

A detailed history of Miramar Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Miramar Capital, LLC holds 110,516 shares of ABT stock, worth $11.4 Million. This represents 3.09% of its overall portfolio holdings.

Number of Shares

110,516

Previous 110,818 0.27%

Holding current value

$11.4 Million

Previous $12.2 Million 2.98%

% of portfolio

3.09%

Previous 3.18%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$109.52 - $120.96 $33,075 - $36,529	-302 Reduced 0.27%	110,516 $12.6 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $357,062 - $437,073	-3,959 Reduced 3.45%	110,818 $12.2 Million
Q3 2023 Nov 07, 2023	SELL	$95.53 - $114.62 $223,349 - $267,981	-2,338 Reduced 2.0%	114,777 $11.1 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $14,512 - $16,169	144 Added 0.12%	117,115 $12.8 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $1.82 Million - $2.14 Million	18,779 Added 19.12%	116,971 $11.8 Million

Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $72,340 - $84,866	761 Added 0.78%	98,192 $10.8 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $576,496 - $667,474	5,958 Added 6.51%	97,431 $9.69 Million
Q2 2022 Aug 03, 2022	BUY	$102.07 - $123.37 $1.42 Million - $1.71 Million	13,878 Added 17.89%	91,473 $9.94 Million
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $1.08 Million - $1.32 Million	9,468 Added 13.9%	77,595 $9.18 Million
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $181,266 - $221,950	1,569 Added 2.36%	68,127 $9.59 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $195,522 - $216,304	1,676 Added 2.58%	66,558 $7.86 Million
Q2 2021 Aug 06, 2021	BUY	$105.79 - $124.53 $245,327 - $288,785	2,319 Added 3.71%	64,882 $7.93 Million
Q1 2021 Apr 27, 2021	SELL	$108.84 - $128.23 $524,173 - $617,555	-4,816 Reduced 7.15%	62,563 $7.5 Million
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $1.21 Million - $1.32 Million	11,560 Added 20.71%	67,379 $8.39 Million
Q3 2020 Oct 13, 2020	SELL	$91.64 - $111.29 $26,575 - $32,274	-290 Reduced 0.52%	55,819 $6.2 Million
Q2 2020 Aug 05, 2020	BUY	$76.57 - $98.0 $121,976 - $156,114	1,593 Added 2.92%	56,109 $5.61 Million
Q1 2020 May 06, 2020	BUY	$62.82 - $91.86 $858,560 - $1.26 Million	13,667 Added 33.46%	54,516 $4.3 Million
Q4 2019 Feb 05, 2020	BUY	$78.51 - $87.4 $719,858 - $801,370	9,169 Added 28.94%	40,849 $3.6 Million
Q3 2019 Oct 22, 2019	BUY	$81.84 - $88.74 $634,751 - $688,267	7,756 Added 32.42%	31,680 $2.59 Million
Q2 2019 Aug 08, 2019	BUY	$72.88 - $85.0 $1.38 Million - $1.6 Million	18,882 Added 374.49%	23,924 $2.11 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $330,553 - $374,469	5,042 New	5,042 $378,000

Others Institutions Holding ABT

# of Institutions

3,129

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $181B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Miramar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miramar Capital, LLC with notifications on news.

Account

Miramar Capital, LLC Abbott Laboratories Transaction History